IIH occurs at a median time of 8–12 weeks when due to CTLA-4 inhibitor use and at a median of 24–26 weeks with PD-1/PD-L1 inhibitor use, although earlier development, at a median of 13.5 weeks, has also been reported [29,34]. This evidence concerns the gene CTLA4 and pseudotumor cerebri.